1. Home
  2. SMTI vs RCS Comparison

SMTI vs RCS Comparison

Compare SMTI & RCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMTI
  • RCS
  • Stock Information
  • Founded
  • SMTI 1982
  • RCS 1994
  • Country
  • SMTI United States
  • RCS United States
  • Employees
  • SMTI N/A
  • RCS N/A
  • Industry
  • SMTI Medical/Dental Instruments
  • RCS Investment Managers
  • Sector
  • SMTI Health Care
  • RCS Finance
  • Exchange
  • SMTI Nasdaq
  • RCS Nasdaq
  • Market Cap
  • SMTI 288.2M
  • RCS 279.8M
  • IPO Year
  • SMTI N/A
  • RCS N/A
  • Fundamental
  • Price
  • SMTI $33.51
  • RCS $7.60
  • Analyst Decision
  • SMTI Buy
  • RCS
  • Analyst Count
  • SMTI 1
  • RCS 0
  • Target Price
  • SMTI $44.00
  • RCS N/A
  • AVG Volume (30 Days)
  • SMTI 24.2K
  • RCS 141.1K
  • Earning Date
  • SMTI 11-12-2024
  • RCS 01-01-0001
  • Dividend Yield
  • SMTI N/A
  • RCS 10.12%
  • EPS Growth
  • SMTI N/A
  • RCS N/A
  • EPS
  • SMTI N/A
  • RCS N/A
  • Revenue
  • SMTI $72,410,222.00
  • RCS N/A
  • Revenue This Year
  • SMTI $26.97
  • RCS N/A
  • Revenue Next Year
  • SMTI $18.91
  • RCS N/A
  • P/E Ratio
  • SMTI N/A
  • RCS N/A
  • Revenue Growth
  • SMTI 21.42
  • RCS N/A
  • 52 Week Low
  • SMTI $26.00
  • RCS $4.51
  • 52 Week High
  • SMTI $43.25
  • RCS $6.31
  • Technical
  • Relative Strength Index (RSI)
  • SMTI 57.04
  • RCS 52.93
  • Support Level
  • SMTI $31.50
  • RCS $7.31
  • Resistance Level
  • SMTI $33.63
  • RCS $7.64
  • Average True Range (ATR)
  • SMTI 1.52
  • RCS 0.14
  • MACD
  • SMTI 0.14
  • RCS -0.01
  • Stochastic Oscillator
  • SMTI 64.69
  • RCS 69.20

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

About RCS PIMCO Strategic Income Fund Inc.

PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with this objective.

Share on Social Networks: